Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP) -- Ignore unavailable to you. Want to Upgrade?

To: Sean Janzen who wrote (857)	3/27/1998 3:24:00 PM
From: Harold Lehman	Read Replies (2) \| Respond to of 1501

It may interest people to know that Dr. Salari may step down as Inflazyme's CEO in the not-too-distant future. They have been interviewing candidates, and at least one of them, a big pharma person who is extremely well qualified, has spent several days in Vancouver. Dr. Salari wants to relinquish the position because he's spreading himself too thin directing the science and trying to cope with the business side of the equation. He would remain as head of science or something like that. I think it would be an extremely positive turn of events to have someone talented and experienced in big pharma business take the reins, making good business decisions and being able to completely follow through. Also, I think Dr. Salari is highly talented in the science of this area, and it would be highly beneficial to IZP if he could devote all of his time to this pursuit. The caveat is that it's not yet signed, sealed and delivered. You can verify this by calling Oona Davis. HL